Wyszukiwarka
Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor
Abstrakt
In 2009 Candida auris was first isolated as fungal pathogen of human disease from ear canal of a patient in Japan. In less than a decade, this pathogen has rapidly spread around the world and has now become a major health challenge that is of particular concern because many strains are resistant to multiple class of antifungal drugs. The lack of available antifungals and rapid increase of this fungal pathogen provides an incentive for the development of new and more potent anticandidal drugs and drug combinatorial treatments. Here we have explored the growth inhibitory activity against C. auris of a synthetic dipeptide glutamine analogue, L-norvalyl-N3-(4-methoxyfumaroyl)-L-2,3- diaminopropanoic acid (Nva-FMDP), that acts as an inhibitor of glucosamine-6-phosphate (GlcN-6-P) synthase - a key enzyme in the synthesis of cell wall chitin. We observed that in contrast to FLC susceptible isolates of C. auris, FLC resistant isolates had elevated cell wall chitin and were susceptible to inhibition by Nva-FMDP. The growth kinetics of C. auris in RPMI-1640 medium revealed that the growth of FLC resistant isolates were 50–60% more inhibited by Nva-FMDP (8 g/ml) compared to a FLC susceptible isolate. Fluconazole resistant strains displayed increased transcription of CHS1, CHS2 and CHS3, and the chitin content of the fluconazole resistant strains was reduced following the Nva-FMDP treatment. Therefore, the higher chitin content in FLC resistant C. auris isolates may make the strain more susceptible to inhibition of the antifungal activity of the Nva-FMDP peptide conjugate
Cytowania
-
1 7
CrossRef
-
0
Web of Science
-
1 5
Scopus
Autorzy (9)
-
Garima Shahi
-
Mohit Kumar
-
Matt Edmondson
-
Atanu Banerjee
-
Jane Usher
-
Neil A.R. Gow
-
Rajendra Prasad
Cytuj jako
Pełna treść
- Wersja publikacji
- Accepted albo Published Version
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1016/j.tcsw.2022.100076
- Licencja
-
otwiera się w nowej karcie
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
Cell Surface
nr 8,
ISSN: - Język:
- angielski
- Rok wydania:
- 2022
- Opis bibliograficzny:
- Shahi G., Kumar M., Skwarecki A., Edmondson M., Banerjee A., Usher J., Gow N. A., Milewski S., Prasad R.: Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor// Cell Surface -Vol. 8, (2022), s.100076-
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1016/j.tcsw.2022.100076
- Źródła finansowania:
-
- Publikacja bezkosztowa
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 127 razy
Publikacje, które mogą cię zainteresować
New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets
- W. Brankiewicz,
- J. Okońska,
- K. Serbakowska
- + 6 autorów
Emerging Anticancer Activity of Candidal Glucoseamine-6-Phosphate Synthase Inhibitors upon Nanoparticle-mediated Delivery usuń
- A. Kertmen,
- Ł. Przysiecka,
- E. Coy
- + 4 autorów
Emerging anticancer activity of candidal glucoseamine-6-phosphate synthase inhibitors upon nanoparticle-mediated delivery
- A. Kertmen,
- J. Przysiecka,
- E. Coy
- + 4 autorów
Peptide dendrimers as antifungal agents and carriers for potential antifungal agent—N3‐(4‐methoxyfumaroyl)‐(S)‐2,3‐ diaminopropanoic acid—synthesis and antimicrobial activity
- M. Stolarska,
- K. Gucwa,
- Z. Urbańczyk-Lipkowska
- + 1 autorów